ZMC(SH:600216) Shang Hai Zheng Quan Bao·2026-01-06 18:42Core Viewpoint - Zhejiang Medicine Co., Ltd. has completed the grant registration of its 2025 Restricted Stock Incentive Plan, awarding 10.284 million shares of restricted stock to 865 participants at a price of 7.30 yuan per share [2][4][6]. Grant Details - Grant Date: November 26, 2025 [3] - Total Shares Granted: 10.244 million shares [4] - Number of Participants: 865, including directors, senior management, and key employees [5] - Grant Price: 7.30 yuan per share [6] - Source of Shares: Shares repurchased from the secondary market [7] Changes in Grant Numbers - The actual number of shares granted decreased from 10.284 million to 10.244 million due to 10 participants voluntarily waiving their rights to a total of 40,000 shares [8]. Registration and Lock-up Period - Registration Date for Restricted Shares: January 5, 2026 [10] - Lock-up Period: 12 months and 24 months for different tranches of shares [11] Performance Assessment - The performance assessment for unlocking the restricted shares will be based on company-level and individual-level evaluations over the 2026-2027 accounting years [12][15]. - Company-level assessments will be categorized into three tiers (A, B, C) based on various business segments [13]. Financial Impact - The funds raised from this incentive plan will be used to supplement the company's working capital [7]. - The accounting costs associated with the restricted stock will be recognized over the vesting period, with potential impacts on the company's financial results [18].